Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marcel Roberfroid is active.

Publication


Featured researches published by Marcel Roberfroid.


Journal of Clinical Gastroenterology | 2003

New scientific paradigms for probiotics and prebiotics.

Gregor Reid; Melinda E. Sanders; H. Rex Gaskins; Glenn R. Gibson; Annick Mercenier; Robert A. Rastall; Marcel Roberfroid; Ian Rowland; Christine Cherbut; Todd R. Klaenhammer

The inaugural meeting of the International Scientific Association for Probiotics and Prebiotics (ISAPP) was held May 3 to May 5 2002 in London, Ontario, Canada. A group of 63 academic and industrial scientists from around the world convened to discuss current issues in the science of probiotics and prebiotics. ISAPP is a non-profit organization comprised of international scientists whose intent is to strongly support and improve the levels of scientific integrity and due diligence associated with the study, use, and application of probiotics and prebiotics. In addition, ISAPP values its role in facilitating communication with the public and healthcare providers and among scientists in related fields on all topics pertinent to probiotics and prebiotics. It is anticipated that such efforts will lead to development of approaches and products that are optimally designed for the improvement of human and animal health and well being. This article is a summary of the discussions, conclusions, and recommendations made by 8 working groups convened during the first ISAPP workshop focusing on the topics of: definitions, intestinal flora, extra-intestinal sites, immune function, intestinal disease, cancer, genetics and genomics, and second generation prebiotics.


Lipids | 1995

Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats

Maria Fiordaliso; Nadine Kok; Jean-Pierre Desager; F. Goethals; Domnique Deboyser; Marcel Roberfroid; Nathalie M. Delzenne

The present study was aimed at answering the question why feeding rats an oligofructose (OFS) supplemented diet could cause a significant reduction in plasma lipid levels. Daily administration of a 10% (w/w) OFS-containing diet to normolipidemic male rats resulted in a decrease in plasma triglycerides, phospholipids and cholesterol. The triglyceride-lowering effect was observed after one week and lasted for at least 16 wk and was associated with a reduction in plasma very low density lipoproteins, indicating that the hypolipidemic effect of OFS may be due to changes in liver lipid metabolism. We therefore tested whether OFS feeding modified the capacity of the liver to synthesize triglycerides from free fatty acids. Hepatocytes isolated from livers of control and OFS-fed rats were incubated in the presence of [1-14C]palmitate, and both intracellular and extracellular [14C]triglyceride formation were quantified. We found that chronic feeding of an OFS-supplemented diet to rats significantly reduced the capacity of isolated hepatocytes to synthesize triglycerides from palmitate. The results suggest that, like other soluble dietary fibers, OFS significantly alters liver lipid metabolism, resulting over time in a significant reduction in plasma triglyceride, phospholipid and cholesterol levels.


Life Sciences | 1995

Effect of fermentable fructo-oligosaccharides on mineral, nitrogen and energy digestive balance in the rat

Nathalie M. Delzenne; Joris Aertssens; H. Verplaetse; M. Roccaro; Marcel Roberfroid

In the present study, we have assessed the apparent retention of gross energy, nitrogen and Ca, Mg, Fe, Zn and Cu in rats receiving a diet supplemented with fermentable fructo-oligosaccharides with high and low degree of polymerization. Feeding 10% Raftilose (degree of polymerization: 4.8) or 10% Raftiline (degree of polymerization: 10) decreased to the same extent (a) the fecal excretion of all the minerals, despite an increase in total fecal mass excretion leading to an improvement of the absorption of Ca, Mg, Fe and Zn; (b) total gross energy absorption; and (c) led to an increase in the faecal excretion and to a decreased urinary excretion of nitrogen, suggesting a displacement of part of nitrogen excretion towards the large intestine. Feeding fermentable fructo-oligosaccharides may thus constitute a good way to counteract syndromes resulting from hyperammonemia or disturbed Fe, Ca, Mg and Zn homeostasis.


Inflammation Research | 2004

Histamine dilutions modulate basophil activation.

P Belon; Jean Cumps; Madeleine Ennis; P F Mannaioni; Marcel Roberfroid; J Sainte-Laudy; F.A.C. Wiegant

AbstractBackground:In order to demonstrate that high dilutions of histamine are able to inhibit basophil activation in a reproducible fashion, several techniques were used in different research laboratories. Objective:The aim of the study was to investigate the action of histamine dilutions on basophil activation. Methods:Basophil activation was assessed by alcian blue staining, measurement of histamine release and CD63 expression. Study 1 used a blinded multi-centre approach in 4 centres. Study 2, related to the confirmation of the multi-centre study by flow cytometry, was performed independently in 3 laboratories. Study 3 examined the histamine release (one laboratory) and the activity of H2 receptor antagonists and structural analogues (two laboratories). Results:High dilutions of histamine (10–30–10–38 M) influence the activation of human basophils measured by alcian blue staining. The degree of inhibition depends on the initial level of anti-IgE induced stimulation, with the greatest inhibitory effects seen at lower levels of stimulation. This multicentre study was confirmed in the three laboratories by using flow cytometry and in one laboratory by histamine release. Inhibition of CD63 expression by histamine high dilutions was reversed by cimetidine (effect observed in two laboratories) and not by ranitidine (one laboratory). Histidine tested in parallel with histamine showed no activity on this model. Conclusions:In 3 different types of experiment, it has been shown that high dilutions of histamine may indeed exert an effect on basophil activity. This activity observed by staining basophils with alcian blue was confirmed by flow cytometry. Inhibition by histamine was reversed by anti-H2 and was not observed with histidine these results being in favour of the specificity of this effect We are however unable to explain our findings and are reporting them to encourage others to investigate this phenomenon.


Xenobiotica | 1982

Hepatic microsomal metabolism of 1,3-butadiene

E. Malvoisin; Marcel Roberfroid

1. In rat liver microsomes, 1,3-butadiene was metabolized to butadiene monoxide, which was subsequently transformed into 3-butene-1,2-diol by microsomal epoxide hydrolase. 2. In the metabolism of butadiene oxide in microsomes, four metabolites were detected, namely two stereoisomers of DL-diepoxybutane, and two stereoisomers of 3,4-epoxy-1,2-butanediol. No meso-diepoxybutane was detected.


Mutation Research | 1977

Mutagenicity of styrene and styrene oxide

C. de Meester; F. Poncelet; Marcel Roberfroid; J. Rondelet; Michel Mercier

Abstract Incubation of S. typhimurium strain TA 1535 with styrene increased the number of his + revertants/plate in presence of a fortified S9 rat-liver fraction. Styrene was also highly cytotoxic for Salmonella cells. Styrene oxide, the presumed first metabolite, had a mutagenic effect towards strains TA 1535 and TA 100 both with and without metabolic activation. Styrene is probably mutagenic because it is metabolized to styrene oxide.


Toxicology Letters | 1992

Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat : in vivo and in vitro studies

Nathalie M. Delzenne; Pedro Buc Calderon; Henryk Taper; Marcel Roberfroid

Until now, the cytotoxicity of the bile acids was mostly seen as being inversely associated with their degree of lipophilicity. The present study aimed at comparing the hepatotoxicity of cholic acid (CA), deoxycholic acid (DCA) and lithocholic acid (LCA), which are respectively, tri-, di- and monohydroxylated bile acids. For in vivo studies, the bile acids have been given at the dose of 0.5% or 1% in the diet of male Wistar rats for 2 weeks. The histological analysis of the liver, and the measurement of serum parameters of cytotoxicity and cholestasis (aminotransferases activity, bilirubin and total bile acids concentration), indicate that, among the bile acids tested, DCA is the most hepatotoxic, at both doses, while CA is the least hepatotoxic and cholestatic compound. Moreover, DCA is the only bile acid which, when given at the dose of 0.5%, induces lipid peroxidation in the liver, as evidenced by the measurement of thiobarbituric reactive substances in liver homogenates. The analysis of bile acids in liver homogenates by gas liquid chromatography revealed that feeding the animals with DCA results in its hepatic accumulation. Feeding rats with LCA or CA only slightly modifies the proportion of tri-, di- and monohydroxylated bile acids in the liver, as compared to controls. An in vitro experiment aimed at studying the hepatocellular lysis induced in vitro by the three bile acids by measuring the release of lactate dehydrogenase in the incubation medium of surviving hepatocytes in suspension. At a concentration of 1 mM, only DCA induces a significant cellular lysis, while at this concentration the lytic effects of CA and LCA are progressive and time-dependent. From this study, we gather that the hepatotoxicity of bile acids does not necessarily depend on their degree of hydroxylation. Our results are in accordance with some studies in rat hepatocarcinogenesis, showing a predominant initiating and promoting effects of DCA, as compared to LCA.


Toxicology and Applied Pharmacology | 1991

The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator.

Awad G. Abdellatif; Véronique Préat; Henryk Taper; Marcel Roberfroid

Perfluorooctanoic acid (PFOA) is a peroxisome proliferator. The aim of this study was to test for its ability to act as a positive modulator of hepatocarcinogenesis, in the so-called biphasic (initiation by diethylnitrosamine 200 mg/kg ip followed by treatment with the suspected modulators) and triphasic (initiation by the same dose of diethylnitrosamine followed by a selection procedure for 2 weeks consisting of giving 2-acetylaminofluorene and in the middle of this treatment a single dose of CCl4 followed by treatment with the suspected modulators) protocols of liver carcinogenesis. In both protocols treatment with PFOA increased the incidence of malignant hepatocellular carcinoma (HCC). As compared to phenobarbital, the modulating effect of PFOA is more pronounced in a biphasic than in the triphasic protocol. In parallel with positive modulation of HCC, PFOA also selectively induced the peroxisomal acyl-CoA oxidase activity and, to a lesser extent, catalase activity.


Journal of Chromatography A | 1979

Identification and quantitation of 1,2-epoxybutene-3 as the primary metabolite of 1,3-butadiene

E. Malvoisin; Georges Lhoëst; F. Poncelet; Marcel Roberfroid; Michel Mercier

Abstract 1,3-Butadiene was incubated in the presence of rat liver microsomes supplemented with an NADPH-generating system. One of the major metabolites of butadiene was found to be 1,2-epoxybutene-3, which was analysed by electron-capture gas—liquid chromatography after its derivatization with pentafluorophenylhydrazine. The effects of variation of several incubation parameters and of different pretreatments of the animals on its formation kinetics were evaluated.


Biochemical and Biophysical Research Communications | 1978

Mutagenicity of butadiene and butadiene monoxide.

Conrad De Meester; F. Poncelet; Marcel Roberfroid; Michel Mercier

Abstract Incubation of S. typhimurium strains TA1530 and TA1535 in the presence of gaseous butadiene increased the number of his+ revertants/plate. This mutagenic effect occured in absence of fortified S-9 rat liver fraction. In its presence, the mutagenic effect seemed to be dependent on its composition. With butadiene monoxide, a reversion to histidine prototrophy was obtained without metabolic activation with strains TA1530, TA1535 and TA100. Butadiene monoxide might be a possible primary metabolite of butadiene.

Collaboration


Dive into the Marcel Roberfroid's collaboration.

Top Co-Authors

Avatar

Michel Mercier

Catholic University of Leuven

View shared research outputs
Top Co-Authors

Avatar

Henryk Taper

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

M. Lans

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

F. Poncelet

Catholic University of Leuven

View shared research outputs
Top Co-Authors

Avatar

C. Razzouk

Catholic University of Leuven

View shared research outputs
Top Co-Authors

Avatar

Véronique Préat

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

J de Gerlache

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

F. Goethals

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

M. Wilpart

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

Nathalie M. Delzenne

Université catholique de Louvain

View shared research outputs
Researchain Logo
Decentralizing Knowledge